Anders D. Hove's most recent trade in Oruka Therapeutics Inc. was a trade of 6,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 30, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Oruka Therapeutics Inc. | Anders D. Hove | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
Oruka Therapeutics Inc. | Anders D. Hove | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
Oruka Therapeutics Inc. | Anders D. Hove | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 12,000 | 12,000 | - | - | Stock Option (right to buy) |